Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024. In terms of the said Scheme, the Company allotted 23,030,622 Equity Shares to the eligible…
What Sanofi files
- Others62
- Important15
- Updates9
- Board Meeting9
- Dividend/Bonus5
- Investor Meet1
Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Result for the quarter and half year ended 30th June 2026.
Sanofi Consumer Healthcare India reported strong Q2 performance with revenue up 7% YoY to ₹235.7 Cr and PBT up 16% to ₹91.9 Cr. H1 revenue grew 18% to ₹464.9 Cr, PBT up 25% to ₹182.6 Cr. Domestic sales climbed 12%, boosted by product relaunches.
Sanofi Consumer Healthcare's board approved the financial results. Q2 revenue hit ₹235.7 Cr, up 7% YoY, with Profit Before Tax at ₹91.9 Cr, a 16% jump. Domestic sales gained 12%, boosted by product relaunches.
Sanofi Consumer Healthcare India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Change in Auditors of the company.